Biotech · Private company
OcuTerra Therapeutics, Inc.
Track this companyFree. Adds OcuTerra Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- OTT166Phase 2 · Diabetic RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- SF0166 Topical Ophthalmic SolutionPhase 2 · Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- SF0166 Topical Ophthalmic SolutionPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle controlPhase 2 · Diabetic RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Nesvategrast (OTT166) in Diabetic Retinopathy (DR)PHASE2 · COMPLETED · started Jul 29, 2022ClinicalTrials.gov NCT05409235 · fetched Nov 12, 2026
- Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)PHASE1_PHASE2 · COMPLETED · started Oct 5, 2016ClinicalTrials.gov NCT02914639 · fetched Nov 12, 2026
- Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)PHASE1_PHASE2 · COMPLETED · started Aug 24, 2016ClinicalTrials.gov NCT02914613 · fetched Nov 12, 2026